Renger John
Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc.
- Sold, on record
- $16.1M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Feb 7, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Cerevel Therapeutics Holdings, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualApr 13, 2022 2022
Sold 45,000 shares at $34.65 ($1.6M)
Renger John, Chief Scientific Officer
Sold 95.8% of holdings ($1.6M position)1,980 shares left1.8x usual sizeFiling
- 2 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualJul 6, 2022 +84 days
Sold 26,105 shares at $30.11 ($786k)
Renger John, Chief Scientific Officer
Sold 90.6% of holdings ($867k position)2,704 shares left0.9x usual sizeFiling
- 3 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualJul 20, 2022 +14 days
Sold 25,000 shares at $30.00 ($750k)
Renger John, Chief Scientific Officer
Sold 90.2% of holdings ($831k position)2,704 shares left1x usual sizeFiling
- 4 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualAug 8, 2022 +19 days
Sold 30,000 shares at $34.25 ($1M)
Renger John, Chief Scientific Officer
Sold 91.7% of holdings ($1.1M position)2,704 shares left1.2x usual sizeFiling
- 5 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualAug 10, 2022 +2 days
Sold 55,000 shares at $40.50 ($2.2M)
Renger John, Chief Scientific Officer
Sold 95.3% of holdings ($2.3M position)2,704 shares left2.1x usual sizeFiling
- 6 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualOct 4, 2022 +55 days
Sold 25,000 shares at $30.00 ($750k)
Renger John, Chief Scientific Officer
Sold 90.2% of holdings ($831k position)2,704 shares left0.9x usual sizeFiling
- 7 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualNov 1, 2022 +28 days
Sold 25,000 shares at $30.00 ($750k)
Renger John, Chief Scientific Officer
Sold 90.2% of holdings ($831k position)2,704 shares left1x usual sizeFiling
- 8 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualFeb 7, 2024 +463 days
Sold 2,161 shares at $41.54 ($90k)
Renger John, Chief Scientific Officer
No 10b5-1 planSold 25.3% of holdings ($354k position)6,370 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | Feb 8, 2024 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 2,161 | $90k | 25.3% | Unusual | SEC |
| Nov 1, 2022 | Nov 3, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $750k | 90.2% | Unusual | SEC |
| Oct 4, 2022 | Oct 6, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $750k | 90.2% | Unusual | SEC |
| Aug 10, 2022 | Aug 12, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 55,000 | $2.2M | 95.3% | Unusual | SEC |
| Aug 8, 2022 | Aug 9, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 30,000 | $1M | 91.7% | Unusual | SEC |
| Jul 20, 2022 | Jul 22, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $750k | 90.2% | Unusual | SEC |
| Jul 6, 2022 | Jul 7, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 26,105 | $786k | 90.6% | Unusual | SEC |
| Apr 13, 2022 | Apr 15, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 45,000 | $1.6M | 95.8% | Unusual | SEC |
| Mar 29, 2022 | Mar 31, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $350k | 83.5% | Unusual | SEC |
| Mar 18, 2022 | Mar 18, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 45,000 | $1.4M | 95.8% | Unusual | SEC |
| Mar 9, 2022 | Mar 11, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 30,000 | $1M | 93.8% | Unusual | SEC |
| Mar 2, 2022 | Mar 4, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $750k | 92.7% | Unusual | SEC |
| Feb 9, 2022 | Feb 11, 2022 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $750k | 92.7% | Unusual | SEC |
| Dec 27, 2021 | Dec 28, 2021 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $350k | 83.5% | Unusual | SEC |
| Dec 21, 2021 | Dec 23, 2021 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 7,300 | $237k | 78.7% | Unusual | SEC |
| Dec 17, 2021 | Dec 17, 2021 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 37,700 | $1.2M | 95.0% | Unusual | SEC |
| Nov 10, 2021 | Nov 15, 2021 | Cerevel Therapeutics Holdings, Inc. | Chief Scientific Officer | Form 4 sale | 55,000 | $2.2M | 100.0% | Unusual | SEC |